Lendlease and other major builders have secured a significant victory in a long-running case brought by the liquidators of failed engineering company Hastie Group, with a judge saying Hastie wasn’t entitled to the proceeds of bank guarantees withdrawn by the builders when it collapsed 10 years ago.
A law firm has filed a class action against Wilson Security on behalf of employees who claim to have been underpaid, just weeks after a court shut down a group proceeding against the company brought by a self-represented worker.
Infant formula maker Care A2 Plus has launched an attack on A2 Milk, filing a lawsuit arguing the dairy giant’s trade marks should be cancelled because they’re too generic and are being used to sell products that don’t exclusively contain the a2 protein.
Pauline Hanson has appealed a defamation judgment ordering her to pay $250,000 to former colleague Brian Burston for “seriously damaging” and malicious comments made in a Today Show interview.
The former manager of over-the-counter derivatives provider Trade360 has been slapped with an eight-year ban by the corporate regulator and has lost a bid to stay the decision pending an appeal.
A judge overseeing two underpayments class actions against supermarket chain Romeo’s has rejected a bid for a private costs assessor by Adero Law, which will now go unpaid until at least January.
Qantas has been hit with a lawsuit by a former female pilot who says she suffered years of sex discrimination and harassment that culminated in a three-hour flight simulation with a hostile instructor that left her “visibly distraught.”
The maker of Finish dishwashing products has appealed a judgment that removed two of its trade marks for non-use and rejected its claim that a competitor’s logo was deceptively similar.
A top orthopaedic surgeon and former NSW Australian of the year has sued Channel Nine and Fairfax for defamation over a recent 60 Minutes episode and articles that appeared in The Age and the Sydney Morning Herald.
Save (1) Please login to bookmark Close Username or Email Address Password Remember Me Swiss pharmaceutical company Biogen and Australian generic drug maker Pharmacor have dropped their claims against one another in a lawsuit over the patent for MS drug Tecfidera. In an October 14 order by Federal Court Justice Helen Rofe, Biogen’s infringement claims…
For information on rights and reprints, contact subscriptions@lawyerly.com.au
